Remove topic market-access
article thumbnail

Covid comments hurt survivors

World of DTC Marketing

In reviewing social media topics and comments on specific health conditions for clients, I determined that more than 75% of posts contained wrong or inaccurate information. Additionally, 49% have accessed a website that provides information about a specific medical condition or problem. This is today’s social media.

Media 218
article thumbnail

The immediate future of DTC

World of DTC Marketing

As we look forward to 2021 DTC marketers should be noting the changes in consumer attitudes and the way they request new treatments. First, let’s dispel a recent topic: telehealth. DTC marketers need to fall out of love with TV and think about how they translate awareness into brand objectives.

Doctors 296
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

CCC to Host Virtual Town Hall on AI, Licensing, and the Path Forward

Copyright Clearance Center

The adoption of AI technology is rapidly growing across industries and the training of these systems requires access to vast amounts of data, including copyrighted content. CCC frequently convenes expert panels to explore complex and important topics in the world of research, publishing, and media.

Training 118
article thumbnail

Healthcare Marketing Trends in 2024: How to StayAhead

Healthcare Success

Now that the holidays have drawn to a close, it’s time to return to your 2024 marketing plan and make adjustments that ensure your business is taking advantage of the latest trends in healthcare marketing to reach patients and HCPs more effectively and make a lasting impression.

article thumbnail

Moderna and UK government sign deal to establish mRNA facility

Pharmaceutical Technology

This Moderna Innovation and Technology Centre (MITC) is expected to offer access to a locally produced future mRNA vaccine portfolio against respiratory viruses, subject to regulatory evaluation and licensure. Topic sponsors are not involved in the creation of editorial content. Free Whitepaper.

article thumbnail

Innovative Medicines Fund and the opportunity for ICSs to mobilise NICE approvals

pharmaphorum

In June, NHSE and NICE published details on the Innovative Medicines Fund, which will help improve patient access to cutting-edge medicines, with a particular focus on rare diseases, and ensure global pharmaceutical and biotech organisations continue to prioritise the UK as a launch destination. Nina is London based.

Medicine 112
article thumbnail

GreenLight and US NIH partner to develop Covid-19 vaccine for variants

Pharmaceutical Technology

In March, the company entered a licensing agreement with Serum Institute of India (SII) to expedite access to messenger RNA products in emerging markets worldwide. Topic sponsors are not involved in the creation of editorial content. Cell & Gene Therapy coverage on Pharmaceutical Technology is supported by Cytiva.